Literature DB >> 23539728

SRGAP1 is a candidate gene for papillary thyroid carcinoma susceptibility.

Huiling He1, Agnieszka Bronisz, Sandya Liyanarachchi, Rebecca Nagy, Wei Li, Yungui Huang, Keiko Akagi, Motoyasu Saji, Dorota Kula, Anna Wojcicka, Nikhil Sebastian, Bernard Wen, Zbigniew Puch, Michal Kalemba, Elzbieta Stachlewska, Malgorzata Czetwertynska, Joanna Dlugosinska, Kinga Dymecka, Rafal Ploski, Marek Krawczyk, Patrick J Morrison, Matthew D Ringel, Richard T Kloos, Krystian Jazdzewski, David E Symer, Veronica J Vieland, Michael Ostrowski, Barbara Jarząb, Albert de la Chapelle.   

Abstract

BACKGROUND: Papillary thyroid carcinoma (PTC) shows high heritability, yet efforts to find predisposing genes have been largely negative.
OBJECTIVES: The objective of this study was to identify susceptibility genes for PTC.
METHODS: A genome-wide linkage analysis was performed in 38 families. Targeted association study and screening were performed in 2 large cohorts of PTC patients and controls. Candidate DNA variants were tested in functional studies.
RESULTS: Linkage analysis and association studies identified the Slit-Robo Rho GTPase activating protein 1 gene (SRGAP1) in the linkage peak as a candidate gene. Two missense variants, Q149H and A275T, localized in the Fes/CIP4 homology domain segregated with the disease in 1 family each. One missense variant, R617C, located in the RhoGAP domain occurred in 1 family. Biochemical assays demonstrated that the ability to inactivate CDC42, a key function of SRGAP1, was severely impaired by the Q149H and R617C variants.
CONCLUSIONS: Our findings suggest that SRGAP1 is a candidate gene in PTC susceptibility. SRGAP1 is likely a low-penetrant gene, possibly of a modifier type.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23539728      PMCID: PMC3644596          DOI: 10.1210/jc.2012-3823

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  30 in total

1.  Signal transduction in neuronal migration: roles of GTPase activating proteins and the small GTPase Cdc42 in the Slit-Robo pathway.

Authors:  K Wong; X R Ren; Y Z Huang; Y Xie; G Liu; H Saito; H Tang; L Wen; S M Brady-Kalnay; L Mei; J Y Wu; W C Xiong; Y Rao
Journal:  Cell       Date:  2001-10-19       Impact factor: 41.582

Review 2.  Cdc42--the centre of polarity.

Authors:  Sandrine Etienne-Manneville
Journal:  J Cell Sci       Date:  2004-03-15       Impact factor: 5.285

3.  F-BAR domain proteins: Families and function.

Authors:  Sohail Ahmed; Wenyu Bu; Raphael Tze Chuen Lee; Sebastian Maurer-Stroh; Wah Ing Goh
Journal:  Commun Integr Biol       Date:  2010-03

Review 4.  RET/PTC rearrangements and BRAF mutations in thyroid tumorigenesis.

Authors:  Raffaele Ciampi; Yuri E Nikiforov
Journal:  Endocrinology       Date:  2006-08-31       Impact factor: 4.736

5.  Thyroid cancer incidence and survival in the national cancer institute surveillance, epidemiology, and end results race/ethnicity groups.

Authors:  Guo-Pei Yu; James Chun-Lun Li; Daniel Branovan; Steven McCormick; Stimson P Schantz
Journal:  Thyroid       Date:  2010-05       Impact factor: 6.568

6.  Papillary thyroid carcinoma associated with papillary renal neoplasia: genetic linkage analysis of a distinct heritable tumor syndrome.

Authors:  C D Malchoff; M Sarfarazi; B Tendler; F Forouhar; G Whalen; V Joshi; A Arnold; D M Malchoff
Journal:  J Clin Endocrinol Metab       Date:  2000-05       Impact factor: 5.958

7.  Germline mutations in breast and ovarian cancer pedigrees establish RAD51C as a human cancer susceptibility gene.

Authors:  Alfons Meindl; Heide Hellebrand; Constanze Wiek; Verena Erven; Barbara Wappenschmidt; Dieter Niederacher; Marcel Freund; Peter Lichtner; Linda Hartmann; Heiner Schaal; Juliane Ramser; Ellen Honisch; Christian Kubisch; Hans E Wichmann; Karin Kast; Helmut Deissler; Christoph Engel; Bertram Müller-Myhsok; Kornelia Neveling; Marion Kiechle; Christopher G Mathew; Detlev Schindler; Rita K Schmutzler; Helmut Hanenberg
Journal:  Nat Genet       Date:  2010-04-18       Impact factor: 38.330

8.  Gene expression and functional evidence of epithelial-to-mesenchymal transition in papillary thyroid carcinoma invasion.

Authors:  Vasily Vasko; Allan V Espinosa; William Scouten; Huiling He; Herbert Auer; Sandya Liyanarachchi; Alexander Larin; Victoria Savchenko; Gary L Francis; Albert de la Chapelle; Motoyasu Saji; Matthew D Ringel
Journal:  Proc Natl Acad Sci U S A       Date:  2007-02-12       Impact factor: 11.205

Review 9.  Rho GTPases in cancer cell biology.

Authors:  Francisco M Vega; Anne J Ridley
Journal:  FEBS Lett       Date:  2008-05-05       Impact factor: 4.124

10.  KELVIN: a software package for rigorous measurement of statistical evidence in human genetics.

Authors:  Veronica J Vieland; Yungui Huang; Sang-Cheol Seok; John Burian; Umit Catalyurek; Jeffrey O'Connell; Alberto Segre; William Valentine-Cooper
Journal:  Hum Hered       Date:  2011-12-23       Impact factor: 0.444

View more
  33 in total

1.  Unraveling the genetic predisposition to differentiated thyroid carcinoma.

Authors:  Albert de la Chapelle
Journal:  J Clin Endocrinol Metab       Date:  2013-10       Impact factor: 5.958

2.  Relationships of FOXE1 and ATM genetic polymorphisms with papillary thyroid carcinoma risk: a meta-analysis.

Authors:  Jie Kang; Xian-Zhao Deng; You-Ben Fan; Bo Wu
Journal:  Tumour Biol       Date:  2014-04-24

3.  Assessing thyroid cancer risk using polygenic risk scores.

Authors:  Sandya Liyanarachchi; Julius Gudmundsson; Egil Ferkingstad; Huiling He; Jon G Jonasson; Vinicius Tragante; Folkert W Asselbergs; Li Xu; Lambertus A Kiemeney; Romana T Netea-Maier; Jose I Mayordomo; Theo S Plantinga; Hannes Hjartarson; Jon Hrafnkelsson; Erich M Sturgis; Pamela Brock; Fadi Nabhan; Gudmar Thorleifsson; Matthew D Ringel; Kari Stefansson; Albert de la Chapelle
Journal:  Proc Natl Acad Sci U S A       Date:  2020-03-04       Impact factor: 11.205

4.  Familiar Papillary Thyroid Carcinoma in a Large Brazilian Family Is Not Associated with Succinate Dehydrogenase Defects.

Authors:  Elen Dias Accordi; Paraskevi Xekouki; Bruna Azevedo; Rodrigo Bertollo de Alexandre; Carla Frasson; Siliane Marie Gantzel; Georgios Z Papadakis; Anna Angelousi; Constantine A Stratakis; Vanessa Santos Sotomaior; Fabio R Faucz
Journal:  Eur Thyroid J       Date:  2016-03-10

Review 5.  An update on familial nonmedullary thyroid cancer.

Authors:  Sabrine A Ammar; Wilson M Alobuia; Electron Kebebew
Journal:  Endocrine       Date:  2020-03-11       Impact factor: 3.633

Review 6.  Mind the (sr)GAP - roles of Slit-Robo GAPs in neurons, brains and beyond.

Authors:  Bethany Lucas; Jeff Hardin
Journal:  J Cell Sci       Date:  2017-11-02       Impact factor: 5.285

Review 7.  Genetic predisposition for nonmedullary thyroid cancer.

Authors:  Rebecca Nagy; Matthew D Ringel
Journal:  Horm Cancer       Date:  2014-10-22       Impact factor: 3.869

8.  Identification of a novel germline FOXE1 variant in patients with familial non-medullary thyroid carcinoma (FNMTC).

Authors:  Joana S Pereira; Joana Gomes da Silva; Rute Alexandra Tomaz; António Evaristo Pinto; Maria João Bugalho; Valeriano Leite; Branca Maria Cavaco
Journal:  Endocrine       Date:  2014-11-09       Impact factor: 3.633

Review 9.  The impact of family history on non-medullary thyroid cancer.

Authors:  I J Nixon; C Suárez; R Simo; A Sanabria; P Angelos; A Rinaldo; J P Rodrigo; L P Kowalski; D M Hartl; M L Hinni; J P Shah; A Ferlito
Journal:  Eur J Surg Oncol       Date:  2016-08-11       Impact factor: 4.424

10.  Germline HABP2 Mutation Causing Familial Nonmedullary Thyroid Cancer.

Authors:  Sudheer Kumar Gara; Li Jia; Maria J Merino; Sunita K Agarwal; Lisa Zhang; Maggie Cam; Dhaval Patel; Electron Kebebew
Journal:  N Engl J Med       Date:  2015-07-30       Impact factor: 91.245

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.